LEVITRA 20mg

Levitra (20mg) is a specialized research reagent utilized primarily to investigate the biochemical pathways of phosphodiesterase type 5 (PDE5) inhibition and the regulation of cyclic guanosine monophosphate (cGMP) signaling. As a potent and selective inhibitor, it is a fundamental tool for exploring smooth muscle relaxation and hemodynamics within vascular tissues. Dragon Pharma provides Levitra 20mg (Vardenafil) at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of vascular biology and urological research, Levitra has become a primary instrument for investigators exploring the nitric oxide (NO) signaling axis. Known scientifically as Vardenafil, this compound offers significantly higher biochemical potency compared to first-generation PDE5 inhibitors, allowing for the study of targeted enzyme kinetics at lower molar concentrations. Dragon Pharma provides Levitra 20mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Compound capable of producing reproducible and accurate data in complex biological models.

As scientific inquiry into pulmonary hypertension, endothelial dysfunction, and cardiovascular resilience expands, the need for high-affinity PDE5 inhibitors like Levitra has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Levitra 20mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Levitra is what allows it to bind to the catalytic site of the PDE5 enzyme with high specificity. By mimicking the structure of cGMP, it prevents the hydrolysis of this critical second messenger.

• Chemical Identity: Vardenafil Hydrochloride
• Molecular Formula: $C_{23}H_{32}N_{6}O_{4}S \cdot HCl$
• Molecular Weight: 525.1 g/mol (as HCl salt)
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Crystalline powder / Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The compound is utilized in various scientific investigative domains, including:

• PDE5 Enzyme Kinetics: Mapping the inhibitory constant ($K_{i}$) and selectivity against other PDE isoforms (PDE1-PDE11).
• Vascular Hemodynamics: Investigating the modulation of corpus cavernosum and pulmonary arterial pressure.
• Nitric Oxide Signaling: Studying the enhancement of the NO-cGMP pathway in endothelial cell models.
• Smooth Muscle Physiology: Assessing the relaxation response of vascular and non-vascular smooth muscle tissues.
• Cardiac Hypertrophy: Evaluating the impact of sustained cGMP elevation on myocardial remodeling and protein kinase G (PKG) activation.

Pathway and Mechanistic Context

The core value of Levitra 20mg in a laboratory setting is its ability to manipulate the cGMP Degradation Pathway without altering the initial synthesis of nitric oxide. In a natural physiological state, PDE5 is the primary enzyme responsible for breaking down cGMP in the vasculature.

The Nitric Oxide-cGMP Axis

Upon inhibition of PDE5 by Levitra, intracellular concentrations of cGMP rise significantly. This initiates a global shift in cellular behavior, promoting the activation of cGMP-dependent protein kinases, which lead to the dephosphorylation of myosin light chains.

Key Mechanistic Shifts:

• Vasodilation Potentiation: Levitra facilitates the relaxation of smooth muscle cells by maintaining high cGMP levels, providing a framework for studying blood flow dynamics.
• Platelet Aggregation Inhibition: It enhances the inhibitory effects of NO on platelet activation, useful for research into thrombotic pathways.
• Cytoprotective Signaling: Researchers use Levitra to observe how the activation of the PKG pathway protects tissues from perceived ischemic or oxidative stress.

Primary Research Applications

1. Urological and Erectile Function Research

Levitra is heavily utilized in studies involving erectile dysfunction (ED) models. Statistics indicate that ED affects approximately 18% of men in the United States, with prevalence varying by racial group; some studies suggest higher rates of diagnosed ED in African American men (14.7%) compared to Caucasian men (10.5%), often linked to higher rates of comorbid diabetes and hypertension. Levitra provides a unique framework for investigating the restoration of vascular responsiveness in these models.

2. Pulmonary Arterial Hypertension (PAH)

Known in research circles for its "vasopressive-relief" potential, Levitra is used to observe how pulmonary vascular tissues adapt to high-pressure environments. Investigators study changes in pulmonary artery remodeling and the prevention of right ventricular hypertrophy in preclinical models.

3. Endothelial Dysfunction and Diabetes

In metabolic research, Levitra is studied for its ability to improve endothelial health in models of Type 2 Diabetes. Research models focus on how PDE5 inhibition can mitigate the vascular damage caused by chronic hyperglycemia and oxidative stress.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Levitra 20mg is produced under strict laboratory conditions to ensure the compound remains stable and potent.

• Stability and Purity: The compound is optimized for long-term stability, removing impurities that could interfere with sensitive enzyme assays.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the verified Vardenafil profile.